Unraveling the stabilisation of proteins
Evaluating the sugars used to stabilise proteins will be faster, cheaper and more efficient thanks to new technology, claim researchers.
Evaluating the sugars used to stabilise proteins will be faster, cheaper and more efficient thanks to new technology, claim researchers.
The revelation that 49 infants died during clinical trials in India has sparked anger among the nation’s congress, with some calling for all studies to be stopped while investigations take place despite the trials having an infant mortality rate (IMR)...
OIMBL’s PharmaSense is a versatile MRI tool that allows drugmakers to assess tablet dynamics and potentially improve API delivery, according to company managing director Frank Trundle.
US-based biotech ArmaGen Technologies has received funding from the Michael J Fox Foundation (MJFF) for the development of its drug delivery technology.
Sweden’s Recipharm hopes that its newly acquired lyophilisation plant will complete its contract services offering and firmly establish it as a player on the CDMO stage.
AstraZeneca and Singapore’s National Cancer Centre (NCCS) have selected inoperable hepatocellular carcinoma (HCC) as the first target for their new drug collaboration.